Organization Overview
anastrozole (arimidex) (1 trial)
asfotase alfa (strensiq) (1 trial)
autologous mononuclear stem cell (1 trial)
bevacizumab (avastin) (1 trial)
cyclophosphamide (cytoxan) (1 trial)
docetaxel (taxotere) (1 trial)
epirubicin (ellence) (1 trial)
Breast Neoplasms (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Cardiomyopathies (Phase 1)
Cardiomyopathy, Dilated (Phase 1)
Central Nervous System Neoplasms (Phase 2)
Cerebrovascular Disorders (Phase 3)
Colonic Neoplasms (Phase 3)
Colorectal Neoplasms (Phase 3)
Coronary Artery Disease (Phase 3)
Coronary Disease (Phase 3)
Gangrene (Phase 2)
Gastrointestinal Stromal Tumors (Phase 2)
Glioblastoma (Phase 2)
Glucose Metabolism Disorders (Phase 3)
Heart Diseases (Phase 2)
Hepatitis C (Phase 3)
Hyperphosphatemia (Phase 3)
Hypophosphatasia (Phase 2)
Hypoplastic Left Heart Syndrome (Phase 2)
Ischemia (Phase 2)
Kidney Diseases (Phase 3)
Kidney Failure, Chronic (Phase 3)
Liver Cirrhosis (Phase 3)
Lung Neoplasms (Phase 2)
Metabolic Diseases (Phase 3)
Myocardial Ischemia (Phase 3)
Neoplasm Metastasis (Phase 2)
Nervous System Neoplasms (Phase 2)
Peripheral Arterial Disease (Phase 2)
Peripheral Vascular Diseases (Phase 2)
Prostatic Neoplasms (Phase 3)
Recurrence (Phase 3)
Renal Insufficiency, Chronic (Phase 3)
Spinal Cord Injuries (Phase 2)
Stroke (Phase 3)
Thyroid Carcinoma, Anaplastic (Phase 2)
Thyroid Diseases (Phase 2)
Thyroid Neoplasms (Phase 2)
Tympanic Membrane Perforation (Phase 3)
Ulcer (Phase 2)
Vascular Diseases (Phase 2)
Wounds and Injuries (Phase 2)